We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$31.5M
NV
2
Northpond Ventures
Maryland
$22.7M
Citadel Advisors
3
Citadel Advisors
Florida
$11.7M -$98.2K -14,211 -0.7%
AG
4
Artal Group
Luxembourg
$10.3M -$21.1K -3,056 -0.2%
DM
5
Deerfield Management
New York
$9.85M -$1.55M -224,610 -11%
BI
6
BVF Inc
California
$9.78M
DTC
7
Deep Track Capital
Connecticut
$9.52M -$43.4K -6,278 -0.4%
BlackRock
8
BlackRock
New York
$4.57M +$178K +25,827 +3%
Vanguard Group
9
Vanguard Group
Pennsylvania
$4.28M +$11.9K +1,730 +0.2%
CAM
10
Cormorant Asset Management
Massachusetts
$3.32M
PBPIA
11
Pivotal bioVenture Partners Investment Advisor
California
$3.02M
RSCM
12
Rock Springs Capital Management
Maryland
$2.54M
O
13
OrbiMed
New York
$2.42M
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.65M +$140K +20,332 +7%
HMC
15
Harvard Management Company
Massachusetts
$1.56M
State Street
16
State Street
Massachusetts
$1.5M +$124K +17,914 +7%
TOCUITCONY
17
Trustees of Columbia University in the City of New York
New York
$1.04M
LGM
18
Logos Global Management
California
$1.02M
DCM
19
DAFNA Capital Management
California
$929K
Goldman Sachs
20
Goldman Sachs
New York
$788K +$920K +133,194 +1,024%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$760K +$4.71K +682 +0.5%
Northern Trust
22
Northern Trust
Illinois
$678K +$9.48K +1,372 +1%
Barclays
23
Barclays
United Kingdom
$564K -$2.15K -312 -0.3%
Citigroup
24
Citigroup
New York
$347K -$33K -4,774 -7%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$261K